ambr® 250
ambr® 250 is a new bioreactor system for parallel fermentation or cell culture using 100-250mL single-use bioreactors controlled by an automated liquid handling platform.The new system, developed with two major industrial partners, builds on the original ambr® microscale technology developed by TAP Biosystems (now part of Sartorius Stedim Biotech).
Receive your quote directly from the manufacturer.
Perfect tool for PD upstream
Process development, media optimization and perfusion
Perfect for the cell cuture development with minimal requirement of man power. Automation plays an important role with the ambr, it is perfect for the PD stage. It reduces your timelines significantly and gives you a room for testing for many parallel experiments.
Review Date: 8 Jun 2022 | Sartorius Group
The new gold standard for process development.
Microbial fermentation
Ambr250 HT, the new standard for the development lab for microbial or mamalian process development, characterization, strain or media/feed screen. Up to 24 vessels can each be dedicated to a specific set of parameters, enabling robust and significant decision making when performing DoE. Add the online analyzer platforms and free time for your lab scientist to switch from actually running the experiment to deeper analysis. The only question that you should ask at a job interview for an upstream position: "Will I get to work on an Ambr250?" If not, run away.
Review Date: 18 May 2020 | Sartorius Group
Ambr250 is inevitable for USP development. Intuitive programming, maximum flexibility.
Upstream process development
5 Years of USP development using the Ambr250 for microbial activities. Everyone in the UPS team is able to program and follow the fermentation regardless their initial level in computer sciences. Jumping from one experiment to another is only a matter of how good you are in planning your activities! The software is DoE friendly and allows you to complete your most bizarre design or up to 12 fermentations at a time with an investigation capability that definitely overtakes what literature says your strain can undergo.
Review Date: 12 Jun 2019 | Sartorius Group
ambr® 250 is a new bioreactor system for parallel fermentation or cell culture using 100-250mL single-use bioreactors controlled by an automated liquid handling platform.
The new system, developed with two major industrial partners, builds on the original ambr® microscale technology developed by TAP Biosystems (now part of Sartorius Stedim Biotech).
